등록된 논문 143건

※ 클릭시 해당 논문페이지로 이동합니다.

• KCSG LU21-11폐암

  A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11)

  • 저널 Clin Lung Cancer. 2022 Dec;23(8):e536-e539.
  • 제1저자 김경환
  • 교신저자 임선민, 윤홍인

• KCSG BR07-03유방암

  A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)

  • 저널 Cancer Res Treat. 2022 Nov 8. doi: 10.4143/crt.2022.1360. Online ahead of print.
  • 제1저자 이대원, 김범석
  • 교신저자 임석아

• KCSG PC21-20완화의료

  Status of Using Complementary and Alternative Medicine among Patients with Cancer in Korea: an Online Survey of Online Cancer Support Groups (KCSG PC21-20)

  • 저널 Cancer Res Treat. 2022 Dec 27.
  • 제1저자 김정선
  • 교신저자 권정혜, 라선영

• KCSG CO17-02대장암

  Preoperative Chemoradiotherapy With Capecitabine With or Without Temozolomide in Patients With Locally Advanced Rectal Cancer: A Prospective, Randomised Phase II Study Stratified by O6-Methylguanine DNA Methyltransferase Status: KCSG-CO17-02

  • 저널 Clin Oncol (R Coll Radiol). 2023 Feb;35(2):e143-e152.
  • 제1저자 오충렬, 김정은
  • 교신저자 홍용상

• KCSG BR19-15/ ST19-16유방암/위암

  Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group

  • 저널 Ther Adv Med Oncol 2022;14:1-13
  • 제1저자 한혜숙, 이경은, 서영주
  • 교신저자 장대영, 박연희, 안형진

• KCSG HB19-14간담췌암

  Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14)

  • 저널 Lancet Gastroenterol Hepatol . 2023 Jan;8(1):56-65.
  • 제1저자 이충근
  • 교신저자 최혜진

• KCSG BR07-02유방암

  Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02)

  • 저널 Breast Cancer Res Treat. 2015 Jul;152(1):77-85.
  • 제1저자 박연희
  • 교신저자 임영혁

• KCSG PC17-01완화의료

  Discussing POLST facilitated hospice care enrollment in patients with terminal cancer.

  • 저널 Support Care Cancer. 2022 Sep;30(9):7431-7438.
  • 제1저자 안호정
  • 교신저자 고수진

• KCSG LU19-22폐암

  Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22

  • 저널 Transl Lung Cancer Res 2022;11(7):1369-1379
  • 제1저자 정현애
  • 교신저자 강진형

• KCSG BR18-23유방암분과

  Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial

  • 저널 JAMA Oncol. 2022 Sep 1;8(9):1271-1277.
  • 제1저자 안희경
  • 교신저자 정경해, 박연희

12345